ArticleBMC public health2026
Prevalence and associated factors of obesity-related hypertension among Malaysian adults: findings from the National Health and Morbidity Survey 2023.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity-related hypertension contributes significantly to cardiovascular risk and poses a major public health concern. This study aimed to determine the prevalence of obesity-related hypertension and its associated factors among Malaysian adults.
methodsData were derived from a nationwide health survey of adults aged ≥ 18 years (n = 10,071) conducted in 2023. Obesity-related hypertension was defined as the concurrent presence of general obesity, abdominal obesity, and hypertension (BMI ≥ 27.5 kg/m² with waist circumference ≥ 90 cm for men and ≥ 80 cm for women, and systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg, or a prior physician diagnosis). Multinomial logistic regression accounting for the complex sampling design was used to identify associated sociodemographic, behavioural, and clinical factors.
resultsThe overall weighted prevalence of obesity-related hypertension among Malaysian adults was 10.0% (95% CI: 9.13, 10.86), while 10.8% (95% CI: 9.93, 11.80) presented with obesity only and 20.0% (95% CI: 18.78, 21.33) with hypertension only. Multinomial logistic regression analysis demonstrated that females (aOR: 1.53; 95% CI: 1.25, 1.86), adults aged 60 years and above (aOR: 2.80; 95% CI: 2.07, 3.77), and individuals with lower educational attainment (aOR: 1.71; 95% CI: 1.17, 2.49) had significantly higher odds of obesity-related hypertension compared with the normal reference group. Additionally, modifiable factors were independently associated with the condition, including physical inactivity (aOR: 1.26; 95% CI: 1.03, 1.55), diabetes mellitus (aOR: 4.49; 95% CI: 3.53, 5.72), and hypercholesterolemia (aOR: 2.30; 95% CI: 1.88, 2.81).
conclusionsObesity-related hypertension affects approximately one in ten Malaysian adults and represents a distinct and significant cardiometabolic burden. The condition is strongly associated with demographic, behavioural, and metabolic factors. These findings highlight the need for integrated, targeted prevention strategies within primary care and national non-communicable disease frameworks to address this growing public health challenge.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.